Pomalyst 4 MG capsule 21S
Ended Awarded
- Contract number
- SPE2DB25FJH11
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,852
Award facts
- Contract value 100% obligated
- $13,851.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,851.75 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pomalyst 4 mg capsules (21-count units). This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by August 29, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle valued through December 2026 that serves as the company's primary mechanism for supplying pharmaceuticals and medical supplies to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly within military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability in competitively awarded delivery orders covering a comprehensive range of pharmaceutical products including specialty medications, vaccines, and medical devices. This specific delivery order for Pomalyst, an immunomodulatory agent used in oncology treatment, reflects the vendor's role in supporting the Defense Logistics Agency's pharmaceutical supply chain across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJH11?
SPE2DB25FJH11 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FJH11 worth?
The government has obligated $13,852 on SPE2DB25FJH11.
Is contract SPE2DB25FJH11 an order under another contract?
Yes. SPE2DB25FJH11 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJH11 competed?
The extent of competition for SPE2DB25FJH11 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award